MOV'D + Fitbit Monitoring for Sedentary Lifestyle

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Stanford University

Disqualifiers: Unsafe to exercise

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

72 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the MOV'D program, which sends short exercise videos and tips via social media to help people take breaks from sitting at work. It targets those who sit a lot and don't get enough exercise, aiming to improve heart health by encouraging regular exercise breaks.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the MOV'D + Fitbit Monitoring treatment safe for humans?

The research does not provide specific safety data for MOV'D + Fitbit Monitoring, but using a Fitbit for tracking physical activity is generally considered safe for most people. ^{1 2 3 4 5}

How is the MOV'D treatment with Fitbit monitoring different from other treatments for a sedentary lifestyle?

The MOV'D treatment is unique because it combines a behavioral approach to encourage regular movement with the use of Fitbit devices to monitor and motivate activity levels, providing real-time feedback and tracking that can help individuals become more aware of their sedentary habits. ^{6 7 8 9 10}

What data supports the effectiveness of the treatment Fitbit Self-Monitoring, MOV'D (Move Often eVery Day) for sedentary lifestyle?

Research shows that wearable devices like Fitbit can help increase physical activity in people with chronic health conditions and cancer survivors, suggesting they may also be effective for reducing sedentary behavior. ^{2 8 11 12 13}

Who Is on the Research Team?

Marily A. Oppezzo, PhD MS, RDN, DipACLM

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.

Inclusion Criteria

English literacy

Safe to exercise, assessed by the Physical Activity Readiness Questionnaire (PAR-Q)

Have smartphone with internet capabilities

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either the MOV'D intervention or a Fitbit-only control for one month

4 weeks

Remote participation

Follow-up

Participants are monitored for changes in MVPA minutes and active workday hours

4 weeks

Remote monitoring

What Are the Treatments Tested in This Trial?

Interventions

• Fitbit Self-Monitoring
• MOV'D (Move Often eVery Day)

Trial Overview The MOV'D program aims to reduce long sitting periods at work using 'exercise snacks'—short bursts of activity—and behavior change techniques shared via social media support groups. Participants will also self-monitor with Fitbit devices.

How Is the Trial Designed?

Group I: MOV'D plus Fitbit Self-Monitoring Experimental Treatment 2 Interventions

Treatment participants will be sent a Fitbit and study-provided account, and assigned to a private, study-created Twitter support group of 10 participants. Within the private group of 10, each participant is also further paired with a peer to be that person's peer coach, setting weekly exercise snack goals and practicing behavior change techniques.

Group II: Fitbit-Only Self-Monitoring Active Control 1 Intervention

Control participants will be sent a Fitbit and study-provided account and will self-monitor physical activity for the duration of the study period (2 months).

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2,527

Recruited

17,430,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials

3,987

Recruited

47,860,000+

National Institutes of Health (NIH)

Collaborator

Trials

2,896

Recruited

8,053,000+

Published Research Related to This Trial

A systematic review of 14 studies found a weak-to-moderate positive association between physical activity measured by wearable activity monitors (WAMs) and performance status (PS) in cancer patients, indicating that more activity may correlate with better performance.

Conversely, there was a weak-to-moderate negative association between sedentary behavior (SB) metrics from WAMs and PS, suggesting that less sedentary time could be linked to improved performance, but WAM data should not replace physician assessments.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The association between wearable activity monitor metrics and performance status in oncology: a systematic review. Kos, M., Pijnappel, EN., Buffart, LM., et al.[2022]

Cancer survivors using wearable activity trackers, like Fitbits, have shown an increase in physical activity, which is important for reducing negative effects from cancer treatments and improving overall health outcomes.

The review identified 13 relevant studies, including 8 randomized controlled trials, indicating a need for further research to better understand how these devices can effectively promote physical activity and weight management in cancer survivors.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies. Coughlin, SS., Caplan, LS., Stone, R.[2020]

Citations

1. United States pubmed.ncbi.nlm.nih.gov

Wearable Technology and Physical Activity Behavior Change in Adults With Chronic Cardiometabolic Disease: A Systematic Review and Meta-Analysis. [2020]

2. United States pubmed.ncbi.nlm.nih.gov

Validity and Reliability of Fitbit Flex for Step Count, Moderate to Vigorous Physical Activity and Activity Energy Expenditure. [2022]

3. Germany pubmed.ncbi.nlm.nih.gov

The association between wearable activity monitor metrics and performance status in oncology: a systematic review. [2022]

4. United States pubmed.ncbi.nlm.nih.gov

The Validity of Consumer-Level Activity Monitors in Healthy Older Adults in Free-Living Conditions. [2019]

5. United States pubmed.ncbi.nlm.nih.gov

Use of consumer wearable devices to promote physical activity among breast, prostate, and colorectal cancer survivors: a review of health intervention studies. [2020]

6. United States pubmed.ncbi.nlm.nih.gov

Feedback from physical activity monitors is not compatible with current recommendations: A recalibration study. [2022]

7. Australia pubmed.ncbi.nlm.nih.gov

Validity and reliability of Fitbit activity monitors compared to ActiGraph GT3X+ with female adults in a free-living environment. [2022]

8. England pubmed.ncbi.nlm.nih.gov

Wearable accelerometer-derived physical activity and incident disease. [2023]

9. United States pubmed.ncbi.nlm.nih.gov

U.S. population profile of time-stamped accelerometer outputs: impact of wear time. [2019]

10. Switzerland pubmed.ncbi.nlm.nih.gov

A Comparison of Sedentary Behavior as Measured by the Fitbit and ActivPAL in College Students. [2021]

11. Netherlands pubmed.ncbi.nlm.nih.gov

Comparing Monitoring Results of Two Motion Trackers for Geriatric Patients. [2020]

12. United States pubmed.ncbi.nlm.nih.gov

Comprehensive comparison of Apple Watch and Fitbit monitors in a free-living setting. [2021]

13. England pubmed.ncbi.nlm.nih.gov

How well does a commercially available wearable device measure sleep in young athletes? [2019]